Aceclofenac + Paracetamol Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100 mg Aceclofenac + 325 mg Paracetamol
Reference Brands: Generic formulations marketed under different names
Category:
Analgesic
Aceclofenac + Paracetamol combines aceclofenac’s inhibition of cyclooxygenase enzymes, reducing inflammation and pain, with paracetamol’s pain and fever relief. Benefits include effective, fast-acting relief from musculoskeletal pain and inflammation, with fewer gastrointestinal side effects. It provides combined anti-inflammatory and analgesic effects for improved patient comfort.
Aceclofenac + Paracetamol tablets is available in Tablets
and strengths such as 100 mg Aceclofenac + 325 mg Paracetamol.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Aceclofenac + Paracetamol tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Aceclofenac + Paracetamol tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Aceclofenac + Paracetamol combination is approved in the EU for pain and inflammation, regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, such combinations are generally not approved, and regulatory approval is pending or unavailable. In Europe, generic formulations are marketed under various brands, adhering to strict standards. Both regions require detailed dossiers, clinical data, and pharmacovigilance for approval. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for aceclofenac + paracetamol, ensuring adherence to European standards for safe, effective analgesic therapy, navigating complex regulations seamlessly.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing